Table 3.

Threshold effect analysis of ALI on all-cause, CVD mortality in patients with T2DM from the NHANES 1999–2018 cohort.

	All -cause mortality
	Per 10U increment	P
<90.20	0.91(0.86,0.97)	0.002
>90.20	1.03(1.00,1.07)	0.04
	CVD mortality
	Per 10U increment	P
<93.06	0.91(0.84,0.98)	0.02
>93.06	1.01(0.98, 1.04)	0.68

ALI, advanced lung cancer inflammation index; CVD, cardiovascular disease; ALT, alanine aminotransferase; Cr, creatinine.

Values are n or weighted HR (95% CI). Model is adjusted for age (years), gender (male or female), race or ethnicity (White, Black, Mexican American, or other), education levels (less than high school, high school or equivalent, or college or above), family income-poverty ratio (<1.3, 1.3-3.5, ≥3.5), smoke status (never, former, or now), alcohol (never, mild to moderate, or heavy), hypertension (yes or no), medication use (no insulin or pills, only diabetes pills, only insulin or both insulin and diabetes pills), ALT (U/L), HbA1c (%), and Cr(umol/L).